CorMedix (CRMD)

• Market cap: $883M
• 1 day: -1.84%
• 5 days: 5.85%
• 1 month: 5.95%
• 3 months: -7.2%
• 6 months: -3.61%
• Year to date: 36.37%
• 1 year: -1.23%
• 5 years: 97.01%
• 10 years: -6.58%
• Sector: Healthcare
• Industry: Biotechnology

About: Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

Employees: 82